Morocco’s Casablanca Stock Exchange is attracting billions of dirhams in new share offerings even as trading volumes decline and stock valuations come under pressure, exposing a widening gap between investor enthusiasm for initial public offerings and demand for shares after they begin trading.
Listings by medical technology group T2S, renewable energy company Jet Energy and pharmaceutical manufacturer Laprophan represent approximately MAD 3.7 billion in completed or planned transactions.
T2S attracted MAD 48.13 billion in subscription requests, exceeding the shares offered by 43.75 times, with more than 111,000 investors participating.
Yet the company’s share price, initially set at MAD 223, illustrates the risks following heavily oversubscribed offerings. Shares rose nearly 20% to MAD 267.55 on their trading debut before subsequently falling below the offering price, reaching MAD 190.10.
Trading activity across the exchange has also weakened. Total transactions fell 54.7% year-on-year to MAD 4.48 billion in October, while average daily trading on the central market declined to MAD 185.5 million from MAD 297 million in September.
Equity investment funds recorded net withdrawals of MAD 1.33 billion over the four weeks ending October 9.
Financial analyst Hassan Belghazi told Hespress that heavy IPO subscriptions do not necessarily indicate fresh, lasting investment, as investors may shift funds from existing shares to new offerings in anticipation of quick gains.
The benchmark MASI index fell to 16,390.9 points on November 3, nearly 13% below its year-opening level, before recovering to 17,429.8 points on November 11, reducing its annual decline to approximately 7.5%.
Banks dominate market capitalisation at MAD 301.16 billion, or roughly 29% of the total, leaving major indices sensitive to movements in a limited number of large companies.
Despite the volatility, listed companies reported combined first-half profits of MAD 29.4 billion, up 12.9%.
The exchange has also introduced futures contracts linked to the MASI 20 index, offering investors new hedging instruments, although trading remains limited.
Attention now turns to Jet Energy, whose MAD 375.4 million offering is scheduled to begin trading on November 16, and Laprophan, which aims to raise up to MAD 2.22 billion ahead of its November 25 debut.
Laprophan’s transaction includes a MAD 1.399 billion capital increase intended to support pharmaceutical expansion, particularly its acquisition of Polymedic, alongside MAD 822.6 million in existing share sales.
The two listings will test whether demand generated during subscriptions translates into sustained trading activity in a market where liquidity has weakened despite renewed interest in new companies.
add your comment
Terms of publication : Not to offend the writer, people, sacred things, or attack religions or the divine self, and refrain from racist incitement and insults.